37
Participants
Start Date
February 23, 2022
Primary Completion Date
December 31, 2022
Study Completion Date
December 31, 2022
Standard Care
Participants will be advised to quit smoking and offered a choice of nicotine replacement patches or varenicline. Participants are free to decline medication.
Precision pharmacotherapy
Participants will be advised to quit smoking and provided a medication recommendation on the basis of their nicotine metabolite ratio (NMR) test (i.e., nicotine replacement patches for slower metabolizers, varenicline for faster metabolizers). Participants are free to choose either medication or decline any medication.
Helen F. Graham Cancer Center & Research Institute, Newark
University of Delaware
OTHER
National Institute of General Medical Sciences (NIGMS)
NIH
Christiana Care Health Services
OTHER